Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q1-2023 Laboratory & Diagnostic Services Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q1-2023 Laboratory & Diagnostic Services Update

Public lab and diagnostic services saw an uptick in Q1 valuations, similar to other verticals within the greater healthcare services market. Despite rising interest rates, healthcare investments continue to show resiliency. The laboratory and diagnostic services sector shows persistent deal flow as consolidation within the sector endures. The appeal of broader test menus, lower costs, increasing health plan coverage, and larger patient networks continues to drive consolidation. Large players, including Quest Diagnostics and Labcorp, further expand their market share through acquisitions suggesting that the lab and diagnostics market will continue to see steady deal flow throughout the course of 2023.

To print and download the full Laboratory & Diagnostic Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/04/Q1-2023-Lab-and-Dx-Newsletter-vF.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]